Dr Marc-Alexander Mahl, 52, will take on the position of chief operating officer from January 1, 2021.
Mahl follows Stefan Eckert, who left the company at the end of 2019. CEO Ingo Müller has been responsible for the unit on an interim basis. Mahl comes from Fresenius Kabi, a company active in the fields of clinical nutrition, infusion therapy, generic drugs and medicinal products. He has been heading up the business unit generics & complex formulations as executive vice president since 2011.
Müller said, “We are pleased to have gained Marc Mahl as a highly experienced manager for this position. His experience will allow him to drive forward the Baby Food business unit. I have come to know Marc Mahl as a positive person with the ability to win people over and inspire them in global teams. He comes to us with the clear remit of ensuring – together with the team –that the Baby Food business area from the Baby business unit will make a successful contribution to the DMK Group result.
“And we’re going to pick up the pace here: through a broad campaign involving various measures, we want and have to create a foundation for generating added value in the Baby Food area in the future. The basis for being able to achieve these ambitious goals is an effective team.”
Mahl said, “Comparatively, the baby food sector is one of the most attractive consumer goods markets worldwide. In the DMK Group’s mission statement for 2030, the Baby BU takes on an important role in growth – the tasks that await me there will allow me to draw on my many years of experience and use it in a new and exciting work environment.”